Abstract：Objective: To study the clinical value of cervista HR-HPV DNA combined with TCT in cervical cancer screening, 500 suspected cervical cancer patients were selected and tested with single cervista HR-HPV DNA, single TCT and cervista HR-HPV DNA combined with TCT. Methods: A total of 500 patients with suspected cervical cancer were selected. Time selection: February 2016 to February 2018, respectively, single cervista HR-HPV DNA test, single TCT test, cervista HR-HPV DNA combined with TCT test, pathological results as a diagnostic gold standards were used to analyze the data of diagnostic specificity, sensitivity, and accuracy of single cervista HR-HPV DNA assay, single TCT assay, and cervista HR-HPV DNA combined with TCT assay. Results: Compared with the single cervista HR-HPV DNA test and single TCT test data, the data of the cervista HR-HPVDNA parallel TCT test was higher than that of the single cervista HR-HPV DNA test. The data difference was significant, P<0.05. However, the cervista HR-HPV DNA was connected in parallel. The diagnostic specificity of TCT was lower than that of single cervista HR-HPV DNA and single TCT. The data was significantly different (P<0.05). The diagnostic specificity, sensitivity and accuracy of single cervista HR-HPV DNA were higher than single TCT. Data were detected and the data were significantly different, P<0.05. Conclusion: The clinical value of cervista HR-HPVDNA combined with TCT in cervical cancer screening is significant, which can improve the diagnostic value of patients and obtain higher diagnostic specificity, sensitivity and accuracy.
于乐, 刘斯文, 张园园, 游园园. Cervista HR-HPV DNA检测联合TCT在宫颈癌筛查中的临床价值[J]. 河北医学, 2019, 25(12): 1969-1972.
YU Le, et al. Clinical Value of Cervista HR-HPV DNA Combined with TCT in Cervical Cancer Screening. HeBei Med, 2019, 25(12): 1969-1972.
[1] Stephanie S. Liu,Karen K. L. Chan,Daniel K. H. Chu, et al.Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer[J].Molecular Oncology,2018,12(12):2009~2022. [2] UlainQurat,HanLu,WuQian, et al.Indocyanine green can stand alone in detecting sentinel lymph nodes in cervical cancer[J].Journal of International Medical Research,2018,46(12):4885~4897. [3] Yingji Jin,Jae Woong Choi,Hyoung Jin Kim, et al.Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer[J].Cancer Medicine,2018,7(11):5655~5664. [4] T. Kurokawa,T. Onuma,A. Shinagawa, et al.The ideal strategy for cervical cancer screening in Japan: result from the fukui cervical cancer screening study[J].Cytopathology,2018,29(4):361~367. [5] Lisa A. Rubinsak,Le Kang,Emma C. Fields, et al.Treatment-related radiation toxicity among cervical cancer patients[J].International Journal of Gynecological Cancer,2018,28(7):1387~1393. [6] 李娟,刘月红,顾萍,等.631例宫颈癌筛查结果分析[J].中国当代医药,2018,25(26):79~81. [7] 郑小平,叶秀丽,陈翌琴.洞头区宫颈癌筛查结果分析[J].预防医学,2018,30(7):743~745. [8] 陆春雪.宫颈癌筛查中阴道镜的应用[J].中国实用乡村医生杂志,2018,25(5):14~17.
2019, Vol. 25 
冀公网安备13080202000677号